- Corbus Pharmaceuticals (NASDAQ:CRBP) FY results: Revenues: $2.4M (+26.3%); Operating Loss: ($32.6M) (-63.0%); Net Loss: ($32.4M) (-62.0%); Loss Per Share: ($0.65) (-32.7%); Quick Assets: $62.5M.
- No guidance given.
- Shares are down 4% premarket on light volume.
Corbus Pharmaceuticals revenues up 26% in FY 2017
Recommended For You
More Trending News
About CRBP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CRBP | - | - |
Corbus Pharmaceuticals Holdings, Inc. |